Toll-like receptor regulation of effector T lymphocyte function

Trends in Immunology

Volumn 34, Issue 10, 2013, Pages 511-519

  Reynolds, Joseph M ^a,b   Dong, Chen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Gamma delta T cells; NKT cells; T lymphocytes; Toll like receptors

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; INTERFERON PRODUCTION; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

GAMMA/DELTA T CELLS; NKT CELLS; T LYMPHOCYTES; TOLL-LIKE RECEPTORS;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 84884812349     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.06.003     Document Type: Review

References (109)

1. Belvin M.P., Anderson K.V. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu. Rev. Cell Dev. Biol. 1996, 12:393-416.
2. Hashimoto C., et al. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988, 52:269-279.
3. Lemaitre B., et al. Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:14614-14619.
4. Meister M., et al. Antimicrobial peptide defense in Drosophila. Bioessays 1997, 19:1019-1026.
5. Medzhitov R., et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
6. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
7. Swamy M., et al. Epithelial decision makers: in search of the 'epimmunome'. Nat. Immunol. 2010, 11:656-665.
8. Blasius A.L., Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315.
9. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 2009, 21:317-337.
10. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
11. Yamamoto M., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
12. West A.P., et al. Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 2006, 22:409-437.
13. Pasare C., Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005, 438:364-368.
14. Rawlings D.J., et al. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 2012, 12:282-294.
15. Caramalho I., et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003, 197:403-411.
16. Sutmuller R.P., et al. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol. 2006, 27:387-393.
17. + T cells. Immunology 2007, 122:149-156.
18. Conroy H., et al. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 2008, 27:168-180.
19. Jin B., et al. The effects of TLR activation on T-cell development and differentiation. Clin. Dev. Immunol. 2012, 2012:836485.
20. Schwandner R., et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 1999, 274:17406-17409.
21. Aliprantis A.O., et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999, 285:736-739.
22. Matsuguchi T., et al. Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood 2000, 95:1378-1385.
23. Poltorak A., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
24. Watanabe T., et al. Lipid A directly inhibits IL-4 production by murine Th2 cells but does not inhibit IFN-γ production by Th1 cells. Eur. J. Immunol. 1999, 29:413-418.
25. Dong C., Flavell R.A. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res. 2000, 2:179-188.
26. Mansson A., et al. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. 2006, 7:36.
27. Hornung V., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002, 168:4531-4537.
28. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 2002, 168:554-561.
29. + T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 2008, 180:1886-1894.
30. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 2007, 19:39-45.
31. Yang X.O., et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007, 282:9358-9363.
32. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.
33. + T cells in chronic colitis. J. Immunol. 2008, 180:5291-5299.
34. Burns K., et al. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 1998, 273:12203-12209.
35. LaRosa D.F., et al. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3855-3860.
36. Zhou S., et al. MyD88 intrinsically regulates CD4 T-cell responses. J. Virol. 2009, 83:1625-1634.
37. Komai-Koma M., et al. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3029-3034.
38. Imanishi T., et al. Cutting edge: TLR2 directly triggers Th1 effector functions. J. Immunol. 2007, 178:6715-6719.
39. Reynolds J.M., et al. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:13064-13069.
40. Sobek V., et al. Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res. Ther. 2004, 6:R433-R446.
41. Chapman N.M., et al. Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells. Cell. Signal. 2013, 25:639-650.
42. + T cell survival and effector function. Mol. Immunol. 2009, 46:3076-3085.
43. + T cells facilitates local immune responses in patients with tuberculous pleurisy. J. Infect. Dis. 2009, 200:399-408.
44. Babu S., et al. Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. J. Immunol. 2006, 176:3885-3889.
45. Park H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
46. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
47. + T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 2010, 32:692-702.
48. H17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 2008, 8:337-348.
49. Nyirenda M.H., et al. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J. Immunol. 2011, 187:2278-2290.
50. + T cells regulates TCR activation and experimental colitis in mice. J. Clin. Invest. 2010, 120:570-581.
51. Zanin-Zhorov A., et al. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J. Immunol. 2007, 179:41-44.
52. Wilson E.H., et al. Trafficking of immune cells in the central nervous system. J. Clin. Invest. 2010, 120:1368-1379.
53. Kamada N., et al. Role of gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13:321-335.
54. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
55. Funderburg N., et al. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS ONE 2008, 3:e1915.
56. + T cell survival. J. Immunol. 2004, 172:6065-6073.
57. + T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 2006, 25:783-793.
58. Bendigs S., et al. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur. J. Immunol. 1999, 29:1209-1218.
59. + T cells through a TLR9- and MyD88-independent mechanism. J. Immunol. 2011, 187:3033-3043.
60. Sharma S., Fitzgerald K.A. Innate immune sensing of DNA. PLoS Pathog. 2011, 7:e1001310.
61. Zheng L., et al. TLR9 engagement on CD4 T lymphocytes represses gamma-radiation-induced apoptosis through activation of checkpoint kinase response elements. Blood 2008, 111:2704-2713.
62. Marsland B.J., et al. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-θ signaling and promote autoimmune myocarditis. J. Immunol. 2007, 178:3466-3473.
63. Alexopoulou L., et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001, 413:732-738.
64. Meyer T., et al. poly(I:C) costimulation induces a stronger antiviral chemokine and granzyme B release in human CD4 T cells than CD28 costimulation. J. Leukoc. Biol. 2012, 92:765-774.
65. Hayashi F., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
66. Hemmi H., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3:196-200.
67. Heil F., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
68. + T cells. J. Immunol. 2005, 175:1551-1557.
69. + T lymphocytes express TLR3 as a functional coreceptor. J. Immunol. 2006, 177:8708-8713.
70. Lee S.M., et al. Expression and function of TLR2 on CD4 versus CD8 T cells. Immune Netw. 2009, 9:127-132.
71. Cottalorda A., et al. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur. J. Immunol. 2006, 36:1684-1693.
72. Mercier B.C., et al. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal. J. Immunol. 2009, 182:1860-1867.
73. + T cells improves their cytokine-mediated proliferation and IFN-γ secretion in the absence of Ag. Eur. J. Immunol. 2009, 39:2673-2681.
74. Mercier B.C., et al. NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells. PLoS ONE 2012, 7:e42170.
75. Asprodites N., et al. Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J. 2008, 22:3628-3637.
76. Geng D., et al. When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function. Blood 2010, 116:3494-3504.
77. Quigley M., et al. A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood 2009, 113:2256-2264.
78. Rahman A.H., et al. MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection. J. Immunol. 2008, 181:3804-3810.
79. Bonneville M., et al. γδ T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 2010, 10:467-478.
80. Reynolds J.M., et al. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 2010, 21:413-423.
81. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
82. Takano M., et al. Protective roles of γδ T cells and interleukin-15 in Escherichia coli infection in mice. Infect. Immun. 1998, 66:3270-3278.
83. Mokuno Y., et al. Expression of toll-like receptor 2 on γδ T cells bearing invariant V γ6/Vδ1 induced by Escherichia coli infection in mice. J. Immunol. 2000, 165:931-940.
84. Spiller S., et al. Cellular recognition of trimyristoylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. J. Biol. Chem. 2007, 282:13190-13198.
85. Erridge C., et al. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J. Med. Microbiol. 2004, 53:735-740.
86. Darveau R.P., et al. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect. Immun. 2004, 72:5041-5051.
87. 3Cys. Infect. Immun. 2006, 74:4505-4511.
88. Pietschmann K., et al. Toll-like receptor expression and function in subsets of human γδ T lymphocytes. Scand. J. Immunol. 2009, 70:245-255.
89. Martin B., et al. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
90. Cai Y., et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 2011, 35:596-610.
91. Hedges J.F., et al. Gamma delta T cells respond directly to pathogen-associated molecular patterns. J. Immunol. 2005, 174:6045-6053.
92. Kress E., et al. Distinct gene expression in human Vδ1 and Vδ2 γδ T cells following non-TCR agonist stimulation. Mol. Immunol. 2006, 43:2002-2011.
93. Shimura H., et al. Up-regulation of cell surface Toll-like receptor 4-MD2 expression on dendritic epidermal T cells after the emigration from epidermis during cutaneous inflammation. J. Dermatol. Sci. 2005, 37:101-110.
94. Schwacha M.G., Daniel T. Up-regulation of cell surface Toll-like receptors on circulating γδ T-cells following burn injury. Cytokine 2008, 44:328-334.
95. Cui Y., et al. Human γδ T cell recognition of lipid A is predominately presented by CD1b or CD1c on dendritic cells. Biol. Direct 2009, 4:47.
96. Wesch D., et al. Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes. J. Immunol. 2006, 176:1348-1354.
97. Beetz S., et al. Innate immune functions of human γδ T cells. Immunobiology 2008, 213:173-182.
98. Peng G., et al. Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007, 27:334-348.
99. Bendelac A., et al. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
100. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 2007, 19:354-364.
101. Godfrey D.I., et al. Raising the NKT cell family. Nat. Immunol. 2010, 11:197-206.
102. Shimizu H., et al. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 2002, 123:1265-1277.
103. Kulkarni R.R., et al. Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists. Cell. Immunol. 2012, 277:33-43.
104. + T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J. Infect. Dis. 2003, 188:1562-1570.
105. Gardner T.R., et al. Toll-like receptor 3 ligand dampens liver inflammation by stimulating Vα 14 invariant natural killer T cells to negatively regulate γδT cells. Am. J. Pathol. 2010, 176:1779-1789.
106. Tsujimoto H., et al. A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells. J. Hepatol. 2006, 45:836-843.
107. Kim J.H., et al. Direct engagement of TLR4 in invariant NKT cells regulates immune diseases by differential IL-4 and IFN-γ production in mice. PLoS ONE 2012, 7:e45348.
108. + NKT cells to initiate contact sensitivity in vivo. J. Immunol. 2005, 175:6390-6401.
109. Holm C.K., et al. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells. J. Immunol. 2009, 183:4422-4431.